Navigation Links
MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
Date:12/20/2011

ROCKVILLE, Md., Dec. 20, 2011 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.  The milestone payment was triggered as part of an agreement executed in October 2010 to discover, develop and commercialize antibody-based therapeutics based on MacroGenics' Dual-Affinity Re-Targeting (DART) platform.  The amount of the milestone payment remained undisclosed.  Therapeutics in the global alliance will be directed against up to ten combinations of molecular targets and may span multiple therapeutic areas, including immunology, oncology, respiratory, cardiometabolic and infectious diseases.  To date, MacroGenics has achieved five pre-clinical milestones across both of its DART collaborations with Boehringer Ingelheim and Pfizer, Inc.

Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics, commented: "We are very encouraged by the progress we've made with this DART candidate in collaboration with Boehringer Ingelheim."  Dr. Koenig continued, "MacroGenics expects to advance multiple product candidates from this alliance in 2012 and beyond."

About MacroGenics
MacroGenics is a private, venture-backed biotechnology company that focuses on the discovery, development and delivery to patients of novel biologics for cancer, autoimmune disorders and infectious diseases. The company has built a fully-integrated set of capabilities in antibody-based product development which supports its innovative pipeline of clinical stage product candidates. MacroGenics' proprietary research is based on three core technology platforms, which include: (1) a leading research capability for screening and targeting cancer stem-like cells; (2) Dual-Affinity Re-Targeting (or DART) bispecific technology, which allows the incorporation of multiple specificities within a single recombina
'/>"/>

SOURCE MacroGenics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MacroGenics Initiates Phase I Clinical Trial of MGAH22 for Patients With HER2-Expressing Solid Tumors
2. MacroGenics Enters Global Research Collaboration and License Agreement with Pfizer
3. MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
4. MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
5. Paulo F. Costa Joins MacroGenics Board of Directors
6. MacroGenics Appoints New Vice President of Business Development
7. MacroGenics Raises $25M in Series D-2 Financing
8. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
9. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
10. Watsons Generic Yaz(R) Receives FDA Approval
11. UCSB professor receives award for graphene electronics research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 DNA Diagnostics Center (DDC), one of ... celebrates its 20 th anniversary today. Headed by ... a consumer services company that focuses on DNA testing ... associates and generates a significant portion of sales across ... Peter Vitulli acknowledges the anniversary ...
(Date:3/3/2015)... VILLAGE, Nev. , March 3, 2015  PDL ... PDLI ) today announced that the third of three ... voluntarily dismissed without prejudice. On February 2, ... Company last September on behalf of a putative class ... Biopharma, Inc., et al., No. 2:14-CV-01526-APG-NJK (D. Nev.), was ...
(Date:3/2/2015)... MD and Fort Washington, PA (PRWEB) March 02, 2015 ... Genetics (ASHG) and ReachMD announced today ... of audio interviews designed to educate healthcare professionals on ... management. , The series features peer-to-peer interviews ... topics such as:, ,     Translational Genomics and ...
(Date:3/2/2015)... Resilinc released online today its 2014 ... and analyzes nearly 700 unique supply chain notifications and ... event monitoring and alert reporting service. Supply chain risk ... of the email service to receive early warnings and ... revenue, market share, customer satisfaction, and shareholder value. ...
Breaking Biology Technology:DNA Diagnostics Center, One of The World's Largest DNA Testing Labs, Celebrates Their 20th Anniversary 2DNA Diagnostics Center, One of The World's Largest DNA Testing Labs, Celebrates Their 20th Anniversary 3PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics 2American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics 3Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 2Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 3
... Organization Recognizes ... SUNNYVALE, Calif., April 30 Accuray,Incorporated (Nasdaq: ARAY ... announced that the company won the Innovations in Healthcare(SM) ... the,"Innovations in Medical/Diagnostics Technology" category., Out of 74 ...
... Board: SCIE), a San Diego based medical device company, ... Optical Biopsy Systems to,the Almeda Company of Prague, Czech ... Prague during colonoscopy to determine if tissue is,normal, pre-cancerous ... are abnormal growths that,stick out from the colon lining ...
... SGI Servers and Storage Systems Fuel Faster Time to Discovery ... Researchers Seeking Causes and Cures of Disease, ... 306/308 -- As scientists seek to accelerate sequencing,genomes of varied ... effort to determine causes and cures of diseases that plague ...
Cached Biology Technology:Accuray Wins Innovations in Healthcare(SM) ABBY Award 2Accuray Wins Innovations in Healthcare(SM) ABBY Award 3Accuray Wins Innovations in Healthcare(SM) ABBY Award 4Sale of Colon Cancer Diagnostic Tool to Czech Republic 2SGI Breakthrough Technology Empowers Genome Center Research Around the World 2SGI Breakthrough Technology Empowers Genome Center Research Around the World 3SGI Breakthrough Technology Empowers Genome Center Research Around the World 4SGI Breakthrough Technology Empowers Genome Center Research Around the World 5
(Date:2/18/2015)... SUNNYVALE, Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Conference, Boston, MA Tuesday, March 3, ... Institutional Investors Conference, Orlando, FL Wednesday, ... Accessing Live Webcasts To access the live webcasts for these ...
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
(Date:2/5/2015)... --NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the growing mobile commerce market, announces the launch ... part of its 2015 marketing and branding initiatives for ... consumer website for Wocketwallet.com earlier this month. ... "Our new corporate website naturally showcases our premiere consumer ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
... Dec. 19, 2008 Researchers at UT Southwestern Medical ... for its role in defending the lungs against invading pathogens ... disease affecting older adults. The same mutation may also be ... the third gene that UT Southwestern scientists have linked with ...
... CA--Future increases in wind strength along the California coast ... cold water along the coast early in the season ... researchers at the Climate Change and Impacts Laboratory at ... scientist Mark Snyder will present the findings in a ...
... Diego and Genentech have developed a new, quicker way ... is many times faster than the sequencing technology typically ... The breakthrough is detailed in the December 2008 issue ... "Automated de novo protein sequencing of monoclonal antibodies." In ...
Cached Biology News:UT Southwestern researchers identify gene linked to inherited form of fatal lung disease 2UT Southwestern researchers identify gene linked to inherited form of fatal lung disease 3Stronger coastal winds due to climate change may have far-reaching effects 2UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology 2UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology 3UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology 4
Request Info...
Cells are grown in triple flasks, roller bottles, or NUNC Factory. Viability and growth curves are generated from a parallel representative culture....
... Covance has generated hybridomas against a ... project initiation, you are provided with ... Hybridoma cell lines developed by Covance ... A typical hybridoma development project has ...
Standard and modified oligonucleotides up to 150 nt-long at any scale for broad applications. Price starts from 30p/base (10 nmole scale)....
Biology Products: